The use of real-world data to generate RWE for medical devices by industry has become more prominent in recent years, and more attractive to a variety of stakeholders. It is used frequently to understand the use of the device in the larger clinical setting, but more recently it is also being used for regulatory decision making. Continue Reading
Bill Fox Chief Strategist for Global Healthcare, Life Sciences, and Insurance MarkLogic In a climate of growing consumer distrust for companies that have access to their personal information, organizations that generate real world evidence must join the likes… Continue Reading
As my writing for the AdverseEvents Blog can attest, I’m in favor of data transparency. In my view, no organization should have monopolistic control over important information that limits the ability for healthcare decision makers to perform unbiased, objective comparative… Continue Reading
